Crossmark

Efficacy and evaluation of dose-response relationship of selective internal radiation therapy for the management of liver metastases in neuroendocrine neoplasia

Crossref DOI link: https://doi.org/10.1007/s00259-026-07762-0

Published Online: 2026-02-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmed, Qasim

Doumanoglou, Nikolaos

Evans, Joanne

Martinez, Maria

Ward, Caroline

Izadi, Hooshang

Wernig, Florian

Bray-Parry, Mark

Nijran, Kuldip

Perry, Laura

Patel, Neva

Bowen, Chloe

Alsafi, Ali

Thomas, Rob

Shah, Tahir

Khagram, Priten

Tait, Paul

Sharma, Rohini
Funding

Funding for this research was provided by:

Boston Scientific Corporation (Boston Scientific Corporation)
License Information

Text and Data Mining valid from 2026-02-17

Version of Record valid from 2026-02-17
More Information

Article History

Received: 23 September 2025

Accepted: 4 January 2026

First Online: 17 February 2026

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Bloomsbury Research NHS Ethics Committee (18/LO/0761) and the UK Health Research Authority (IRAS ID 231087). The administration of radioactivity was approved by the Administration of Radioactive Substances Advisory Committee, U.K (R190).

: Written informed consent was obtained from all individual participants included in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below